Central pontine myelinolysis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| It has been suggested that this article or section be merged with Osmotic demyelination syndrome. (Discuss) |
| Central pontine myelinolysis Classification and external resources | |
 | |
|---|---|
| Pons labeled at bottom left | |
| ICD-10 | G37.2 |
| DiseasesDB | 2198 |
| MedlinePlus | 000775 |
| eMedicine | neuro/50 |
| MeSH | D017590 |
Central pontine myelinolysis is a neurologic disease caused by severe damage of the myelin sheath of nerve cells in the brainstem, more precisely in the area termed the pons.
Contents |
Causes
The most common cause is the rapid correction of low blood sodium levels (hyponatremia).
Some scholars postulate that the real cause might be the lack of a substance that is essential for brain activity and is lacking due to malnutrition.
The fact that this condition is most frequently observed in patients with general ill health (alcoholism, cachexia etc.) is in accordance with this assumption. [1]
Diagnosis
Imaging by MRI demonstrates an area of high signal return on T2 weighted images.
Symptoms
Frequently observed symptoms in this disorder are sudden para or quadraparesis, dysphagia, dysarthria, double vision and loss of consciousness. The patient may experience locked-in syndrome where cognitive function is intact, but all muscles are paralyzed with the exception of eye blinking.
Treatment
To avoid myelinolysis, the correction of hyponatremia should not exceed 1 mEq/L per hour. [1][1]
References
- Gocht A , Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropath. 1987;6:262–70. PMID 3322623
- Menger H , Jorg J. Outcome of central pontine and extrapontine myelinolysis (n=44). J Neurol. 1999;246:700–5. PMID 10460448
